The Qualcomm-backed electronics maker will float the bottom of its range, in an offering that is still the largest for a tech company since 2014.

The Axel Johnson-backes apparel fitting technology developer has been bought by a group of Japanese investors for $12.7m.

The live video streaming platform, which is backed by Kunlun Tech, Duomi and Tencent, has set the terms for its initial public offering.

The messenger RNA drug developer, backed by Monsanto, Merck & Co, GlaxoSmithKline, Pfizer and Merck Group, has raised more than $121m in its initial public offering.

Karolinska Development has sold its remaining stake in BioArctic, which is based on research at Uppsala University and floated on Nasdaq Stockholm last year.

Johns Hopkins-backed biopharmaceutical developer Allakos has filed for a $75m initial public offering after raising more than $160m in equity funding.

Avexis, which is commercialising research from Ohio State University and Nationwide Children's Hospital, has been acquired by Novartis for $8.7bn.

UC Investment Office-backed gene expression technology developer Constellation Pharmaceuticals has filed for an $86.3m initial public offering.

SR One-backed gene expression technology developer Constellation Pharmaceuticals has filed for an $86.3m initial public offering.